Address
Email address
Phone number
Krka is one of the leading generic pharmaceutical companies with nearly 70 years of experience. Today, the high quality of our products is recognised all over the world.
Name
KRKA, d.d., Novo Mesto Eesti filiaal
Registry code
10018194
Type
FIL - Branch
Status
Registered
Foundation date
15.03.1996 (28)
Financial year
01.01-31.12
Capital
233 801 242.00 €
Activity
70221 - Business and other management consultancy activities
-
-
-
-
-
-
Submitted
No tax arrears
-
-
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Merit Kiili 02.11.1967 (57) | - | Branch manager | - |
2019 04.05.2020 | 2020 19.04.2021 | 2021 18.04.2022 | 2022 24.04.2023 | 2023 25.04.2024 | |
---|---|---|---|---|---|
Total Revenue | - | - | - | - | - |
Net profit (loss) for the period | - | - | - | - | - |
Profit Margin | - | - | - | - | - |
Current Assets | - | - | - | - | - |
Fixed Assets | - | - | - | - | - |
Total Assets | - | - | - | - | - |
Current Liabilities | - | - | - | - | - |
Non Current Liabilities | - | - | - | - | - |
Total Liabilities | - | - | - | - | - |
Share Capital | - | - | - | - | - |
Equity | - | - | - | - | - |
Employees | - | - | - | - | - |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | - | 76 803.86 € | 80 660.13 € | 19 |
2023 Q4 | - | 98 913.4 € | 103 767.97 € | 18 |
2023 Q3 | - | 85 557.86 € | 90 544.55 € | 18 |
2023 Q2 | - | 33 136.38 € | 74 809.7 € | 18 |
2023 Q1 | - | 110 782.18 € | 116 037.22 € | 17 |
2022 Q4 | - | 98 462.27 € | 103 549.03 € | 18 |
2022 Q3 | - | 88 004.99 € | 92 918.75 € | 17 |
2022 Q2 | - | 35 241.16 € | 82 108.67 € | 16 |
2022 Q1 | - | 78 420.95 € | 83 023.53 € | 15 |
2021 Q4 | - | 70 801.08 € | 74 859.45 € | 15 |
2021 Q3 | - | 82 558.17 € | 87 368.47 € | 16 |
2021 Q2 | - | 28 962.29 € | 76 103.03 € | 16 |
2021 Q1 | - | 73 746.21 € | 78 856.62 € | 17 |
2020 Q4 | - | 89 055.72 € | 95 127.99 € | 16 |
2020 Q3 | - | 78 557.93 € | 83 907.96 € | 19 |
2020 Q2 | - | 28 752.77 € | 76 063.95 € | 17 |
2020 Q1 | - | 74 225.1 € | 79 356.18 € | 17 |